Fresenius Medical Care AG 2026 Q2 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- The company delivered another quarter of highly profitable growth with operating income growth accelerating to 23% in Q2 2026, supported by solid organic revenue development and margin expansion.
- Organic revenue growth was 5% in Q2 2026, with constant currency revenue up 4%, driven by all three operating segments.
- Care delivery segment achieved 5% revenue growth at constant currency and 7% organic growth in the US, supported by reimbursement regulations, favorable rate development, and revenue cycle management initiatives, despite lower treatment volumes due to referral dynamics.
- Value based care segment revenue grew 9% organically and at constant currency, with operating income improving to €18 million from a €9 million loss in the prior year, and margin improving by 500 basis points.
- Care enablement segment delivered 3% organic revenue growth, supported by positive pricing and volumes outside China, though earnings declined 5% due to regulatory impacts in China and increased inflationary pressures including raw material and logistics costs.
- The FM 25 plus transformation program delivered €67 million of sustainable savings during the quarter.
- The company completed its initial €1 billion share buyback program on an accelerated timeline and launched a second €1 billion program, maintaining a net leverage ratio of 2.6 times.
- Special items in Q2 included a -€103 million impact mainly related to the European Commission's recommended revocation of the toughness marketing authorization, leading to impairment of intangible assets and a €71 million negative impact on income from equity method investees.
- Operating cash flow increased 11% in Q2 2026, driven by disciplined working capital management, while free cash flow remained stable at €625 million despite increased investments.
- The 5008 X rollout accelerated as planned, with 227 clinics converted across 23 states representing 10% of the machine base, and more than 600,000 treatments performed on the 5008 X to date.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Ladies and gentlemen, welcome to the report on second quarter 2026 earnings release and conference call. I am Valentina, the call's co-operator. I would like to remind you that all participants will be in listen-only mode, and the conference is being recorded. Presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and one on your telephone. For operator assistance, please press star and zero. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Dr. Dominik Heger.
Please go ahead. Thank you, Valentina.
I would like to welcome everyone to our earnings call for the second quarter of 2026. I appreciate your flexibility to join this earlier call. We felt it is more helpful to have the call earlier, given that we had to publish earlier than originally planned. I do apologize for the inconvenience, in particular for those of you who are located in a different time zone or those of you who cover another company hosting a call in parallel right now. As always, I start out the call by mentioning our caution in language that is in our safe harbor statement, as well as in our presentation and in all the materials that we have distributed earlier today. For further details concerning risks and uncertainties, please refer to these documents and to our SEC filings. The call is scheduled for one hour.
In order to give everyone the chance to ask questions, we would limit the number of questions, as always, to two. Thank you for making this work. Let me now welcome Helen Giza, CEO and Chair of the Management Board, and Martin Fischer, our Chief Financial Officer. Helen, the floor is yours.
Call participants
14 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring